Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs.
about
Immune-induced evolutionary selection focused on a single reading frame in overlapping hepatitis B virus proteins.Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy.Research progress of therapeutic vaccines for treating chronic hepatitis B.Intensity of HLA-A2 Expression Significantly Decreased in Occult Hepatitis B Infection.Immune response to fused core protein of hepatitis C virus and truncated tetanus toxin peptides in mice.
P2860
Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@ast
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@en
type
label
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@ast
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@en
prefLabel
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@ast
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@en
P2093
P2860
P356
P1476
Therapeutic polypeptides based ...... xicity in HLA-A2+ human PBMCs.
@en
P2093
Li-Yun Zou
Tong-Dong Shi
Yu-Zhang Wu
Zheng-Cai Jia
P2860
P304
P356
10.3748/WJG.V10.I13.1902
P407
P577
2004-07-01T00:00:00Z